Cargando…
Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease
Impaired mitophagy is one of the hallmarks of the pathogenesis of Parkinson’s disease, which highlights the importance of the proper functioning of mitochondria, as well as the processes of mitochondrial dynamics for the functioning of dopaminergic neurons. At the same time, the main factors leading...
Autores principales: | Blagov, Alexander V., Goncharov, Andrey G., Babich, Olga O., Larina, Viktoriya V., Orekhov, Alexander N., Melnichenko, Alexandra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696222/ https://www.ncbi.nlm.nih.gov/pubmed/36432705 http://dx.doi.org/10.3390/pharmaceutics14112514 |
Ejemplares similares
-
The Roles of PINK1 and Parkin in Parkinson's Disease
por: Jones, Rachel
Publicado: (2010) -
Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease
por: Blagov, Alexander V., et al.
Publicado: (2023) -
Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011) -
PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
por: Mouton-Liger, Francois, et al.
Publicado: (2017) -
Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis
por: Blagov, Alexander V., et al.
Publicado: (2022)